Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer With ERBB2/3 Amplification, Overexpression, or Mutation: Results From the TAPUR Study A total of 11 gastrointestinal cancers were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results